Hide and seek with antineutrophil cytoplasmic antibodiesALICANDRI-CIUFELLI, Matteo; MOLTENI, Gabriele; MASCIA, Maria Teresa et al.American journal of otolaryngology (Print). 2010, Vol 31, Num 5, pp 397-398, issn 0196-0709, 2 p.Article

Anticorps anticytoplasme des polynucléaires neutrophiles (ANCA): ce que le dermatologue doit savoir = Antineutrophil cytoplasmic antibodies: What the dermatologist should knowINGEN-HOUSZ-ORO, S; HÜE, S.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 8-9, pp 594-598, issn 0151-9638, 5 p.Article

Antineutrophil cytoplasmic antibodiesBOSCH, Xavier; GUILABERT, Antonio; FONT, Josep et al.Lancet (British edition). 2006, Vol 368, Num 9533, pp 404-418, issn 0140-6736, 15 p.Article

ANCA Disease: Where Is This Field Heading?FALK, Ronald J; JENNETTE, J. Charles.Journal of the American Society of Nephrology. 2010, Vol 21, Num 5, pp 745-752, issn 1046-6673, 8 p.Article

Antineutrophil cytoplasmic antibodies (ANCA)RADICE, A; SINICO, R. A.Autoimmunity (Print). 2005, Vol 38, Num 1, pp 93-103, issn 0891-6934, 11 p.Article

La recherche des ANCA est positive: Eh bien !YOUINOU, Pierre; SARAUX, Alain.Rhumatos. 2010, Vol 7, Num 60, pp 249-250, issn 1771-0081, 2 p., CAH1Article

Cutaneous sarcoid-like granulomas with alveolar hemorrhage and c-ANCA PR-3ROCHA, Natividade; VELHO, Gloria; RODRIGUES, Manuel et al.International journal of dermatology. 2004, Vol 43, Num 9, pp 668-672, issn 0011-9059, 5 p.Article

Renal Involvement in Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody-positive Granulomatosis with Polyangiitis with Chronic Hypertrophic PachymeningitisHASEGAWA, Hisanori; KOHSAKA, Hitoshi; TAKADA, Kazuki et al.Journal of rheumatology. 2012, Vol 39, Num 10, pp 2053-2055, issn 0315-162X, 3 p.Article

Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In VivoNOLAN, Sarah L; KALIA, Neena; NASH, Gerard B et al.Journal of the American Society of Nephrology. 2008, Vol 19, Num 5, pp 973-984, issn 1046-6673, 12 p.Article

Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitisTHICKETT, D. R; RICHTER, A. G; NATHANI, N et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 3, pp 261-268, issn 1462-0324, 8 p.Article

Clinical utility of ANCA tests for the dermatologistGIBSON, Lawrence E; SPECKS, Ulrich; HOMBURGER, Henry et al.International journal of dermatology. 2003, Vol 42, Num 11, pp 859-869, issn 0011-9059, 11 p.Article

Cutaneous leukocytoclastic vasculitis with positive anti-neutrophil cytoplasmic antibodiesDAOUD, M. S; GIBSON, L. E; SPECKS, U et al.Acta dermato-venereologica. 1999, Vol 79, Num 4, pp 328-329, issn 0001-5555Article

I. - Aspects fondamentaux = I. -Fundamental aspectLa Semaine des hôpitaux de Paris. 1999, Vol 75, Num 29-30, pp 1146-1152, issn 0037-1777Conference Proceedings

Genetically Distinct Subsets within ANCA-Associated VasculitisLYONS, Paul A; RAYNER, Tim F; COHEN TERVAERT, Jan Willem et al.The New England journal of medicine. 2012, Vol 367, Num 3, pp 214-223, issn 0028-4793, 10 p.Article

ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular processHOLDEN, N. J; WILLIAMS, J. M; MORGAN, M. D et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 12, pp 2229-2233, issn 0003-4967, 5 p.Article

Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to I nfl ixi mab in Patients With Ulcerative Col itisJÜRGENS, Matthias; LAUBENDER, Rüdiger P; SCHNITZLER, Fabian et al.The American journal of gastroenterology. 2010, Vol 105, Num 8, pp 1811-1819, issn 0002-9270, 9 p.Article

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitidesTERRIER, B; SAADOUN, D; SENE, D et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 10, pp 1564-1571, issn 0003-4967, 8 p.Article

Antineutrophil Cytoplasmic Antibody-Associated Active ScleritisHOANG, Lani T; LIM, Lyndell L; VAILLANT, Brian et al.Archives of ophthalmology (1960). 2008, Vol 126, Num 5, pp 651-655, issn 0003-9950, 5 p.Article

International Vasculitis and ANCA WorkshopClinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 1, issn 0392-856X, S45-S79, SUP44Conference Paper

The effect of a symptom related gating policy on ANCA requests in routine clinical practiceSINCLAIR, D; SAAS, M; STEVENS, J. M et al.Journal of clinical pathology. 2004, Vol 57, Num 2, pp 131-134, issn 0021-9746, 4 p.Article

Estimating Renal Survival Using the ANCA-Associated GN ClassificationHILHORST, Marc; WILDE, Benjamin; VAN BREDA VRIESMAN, Peter et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 9, pp 1371-1375, issn 1046-6673, 5 p.Article

An unusual presentation of C-ANCA vasculitisGAVRILOVSKI, M; KAKAR, P; RENDLE, J et al.QJM (Oxford. 1994. Print). 2012, Vol 105, Num 11, pp 1105-1107, issn 1460-2725, 3 p.Article

Maintenance Immunosuppression in Antineutrophil Cytoplasmic Antibody-Associated VasculitisCATTRAN, Daniel C; HLADUNEWICH, Michelle A.American journal of kidney diseases. 2011, Vol 57, Num 6, pp 818-821, issn 0272-6386, 4 p.Article

Pulmonary haemorrhage in ANCA-associated vasculitisRAVINDRAN, Vinod; WATTS, Richard A.Rheumatology (Oxford. Print). 2010, Vol 49, Num 7, pp 1410-1412, issn 1462-0324, 3 p.Article

p-ANCAs in autoimmune liver disorders recognise human β-tubulin isotype 5 and cross-react with microbial protein FtsZTERJUNG, Birgit; SÖHNE, Jennifer; LECHTENBERG, Berthold et al.Gut. 2010, Vol 59, Num 6, pp 808-816, issn 0017-5749, 9 p.Article